FGF2 and cancer: Moreover, direct (through gap junction and calcium signaling) and indirect (through fibroblast growth factor 2 (FGF2) and platelet-derived growth factor-DD (PDGF-DD) secretion) interactions between cancer cells and osteogenic cells leads to a reduction in estrogen receptors.